Literature DB >> 23115014

Explaining freezing of gait in Parkinson's disease: motor and cognitive determinants.

Sarah Vercruysse1, Hannes Devos, Liesbeth Munks, Joke Spildooren, Jochen Vandenbossche, Wim Vandenberghe, Alice Nieuwboer, Elke Heremans.   

Abstract

Freezing of gait (FOG) is part of a complex clinical picture in Parkinson's disease (PD) and is largely refractory to standard care. Diverging hypotheses exist about its origins, but a consolidated view on what determines FOG is lacking. The aim of this study was to develop an integrative model of FOG in people with PD. This cross-sectional study included 51 Parkinson subjects: 24 patients without FOG and 27 with FOG matched for age, gender, and disease severity. Subjects underwent an extensive clinical test battery evaluating general disease characteristics, gait and balance, nongait freezing, and cognitive functions. The relative contribution of these outcomes to FOG was determined using logistic regression analysis. The combination of the following four independent contributors provided the best explanatory model of FOG (R(2) = 0.49): nongait freezing; levodopa equivalent dose (LED); cognitive impairment; and falls and balance problems. The model yields a high-risk profile for FOG (P > 95%) when Parkinson patients are affected by at least one type of nongait freezing (e.g., freezing of other repetitive movements), falls or balance problems during the last 3 months, and a Scales for Outcomes in Parkinson's Disease-Cognition score below 28. A high LED further increases the risk of FOG to 99%. Nongait freezing, increased dopaminergic drug dose, cognitive deficits, and falls and balance problems are independent determinants of FOG in people with PD and may play a synergistic role in its manifestation.
Copyright © 2012 Movement Disorder Society.

Entities:  

Mesh:

Year:  2012        PMID: 23115014     DOI: 10.1002/mds.25183

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  29 in total

Review 1.  Managing Gait, Balance, and Posture in Parkinson's Disease.

Authors:  Bettina Debû; Clecio De Oliveira Godeiro; Jarbas Correa Lino; Elena Moro
Journal:  Curr Neurol Neurosci Rep       Date:  2018-04-06       Impact factor: 5.081

2.  A novel single-sensor-based method for the detection of gait-cycle breakdown and freezing of gait in Parkinson's disease.

Authors:  Taylor Chomiak; Wenbiao Xian; Zhong Pei; Bin Hu
Journal:  J Neural Transm (Vienna)       Date:  2019-06-01       Impact factor: 3.575

3.  Changes in oxygenated hemoglobin link freezing of gait to frontal activation in patients with Parkinson disease: an fNIRS study of transient motor-cognitive failures.

Authors:  Inbal Maidan; Hagar Bernad-Elazari; Eran Gazit; Nir Giladi; Jeffery M Hausdorff; Anat Mirelman
Journal:  J Neurol       Date:  2015-01-31       Impact factor: 4.849

Review 4.  Freezing of gait in Parkinson's disease: where are we now?

Authors:  Elke Heremans; Alice Nieuwboer; Sarah Vercruysse
Journal:  Curr Neurol Neurosci Rep       Date:  2013-06       Impact factor: 5.081

5.  Baseline cognitive profile is closely associated with long-term motor prognosis in newly diagnosed Parkinson's disease.

Authors:  Seok Jong Chung; Han Soo Yoo; Hye Sun Lee; Yang Hyun Lee; KyoungWon Baik; Jin Ho Jung; Byoung Seok Ye; Young H Sohn; Phil Hyu Lee
Journal:  J Neurol       Date:  2021-05-04       Impact factor: 4.849

6.  Frontal theta and beta oscillations during lower-limb movement in Parkinson's disease.

Authors:  Arun Singh; Rachel C Cole; Arturo I Espinoza; Darin Brown; James F Cavanagh; Nandakumar S Narayanan
Journal:  Clin Neurophysiol       Date:  2020-01-13       Impact factor: 3.708

7.  Modeling falls in Parkinson's disease: Slow gait, freezing episodes and falls in rats with extensive striatal dopamine loss.

Authors:  Aaron Kucinski; Roger L Albin; Cindy Lustig; Martin Sarter
Journal:  Behav Brain Res       Date:  2015-01-14       Impact factor: 3.332

8.  Co-treatment with rivastigmine and idalopirdine reduces the propensity for falls in a rat model of falls in Parkinson's disease.

Authors:  Ajeesh Koshy Cherian; Aaron Kucinski; Ryan Wu; Inge E M de Jong; Martin Sarter
Journal:  Psychopharmacology (Berl)       Date:  2019-01-04       Impact factor: 4.530

Review 9.  Cognitive aspects of freezing of gait in Parkinson's disease: a challenge for rehabilitation.

Authors:  Elke Heremans; A Nieuwboer; J Spildooren; J Vandenbossche; N Deroost; E Soetens; E Kerckhofs; S Vercruysse
Journal:  J Neural Transm (Vienna)       Date:  2013-01-18       Impact factor: 3.575

Review 10.  Therapy-resistant symptoms in Parkinson's disease.

Authors:  Ruxandra Julia Vorovenci; Roberta Biundo; Angelo Antonini
Journal:  J Neural Transm (Vienna)       Date:  2015-09-26       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.